Study of KBA1412 in Participants With Advanced Solid Malignant Tumors

Safety and Preliminary Efficacy of BNT314 in Cancer Patients With Malignant Solid Tumors

NCT06150183 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Phase 1 Multicenter Open-label Study to Evaluate the Safety Tolerability and PK of MEDI0680 (AMP-514) in Subjects With Advanced Malignancies

NCT02013804 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial of TB511 in Advanced Solid Tumors

NCT06400160 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors

NCT02988960 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies

NCT02712905 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid Tumors

NCT07215637 ·Status: RECRUITING ·Phase: PHASE1

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

NCT05311618 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study of KM501 in Patients With Solid Tumors

NCT05804864 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Safety, Tolerability, and Pharmacokinetics of MW11 in Patients With Advanced Solid Tumors

NCT04478461 ·Status: UNKNOWN ·Phase: PHASE1

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

NCT04370587 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors

NCT03821935 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study of YL242 in Subjects With Advanced Solid Tumors

NCT07197827 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Safety and Pharmacokinetic Profile of CKD-581

NCT01580371 ·Status: COMPLETED ·Phase: PHASE1

This is an Open Label, Two-part, Multicenter, Phase I Trial to Investigate the Safety, Tolerability, and PK of KGX101 Monotherapy and Combination Therapy With Envafolimab in Patients With Advanced or Metastatic Solid Tumors.

NCT06074497 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study of MK-6598 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-6598-001)

NCT05594043 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT03071757 ·Status: COMPLETED ·Phase: PHASE1

A Study of DS5361b in Participants With Advanced Solid Tumors

NCT07182591 ·Status: RECRUITING ·Phase: PHASE1

Study of XL184 (Cabozantinib) in Adults With Advanced Malignancies

NCT00215605 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of SAR408701 in Patients With Advanced Solid Tumors

NCT02187848 ·Status: TERMINATED ·Phase: PHASE1

QUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid Tumors

NCT00974896 ·Status: COMPLETED ·Phase: PHASE1

BMS-247550 in Treating Patients With Advanced Cancers

NCT00006221 ·Status: COMPLETED ·Phase: PHASE1

BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment

NCT00005611 ·Status: UNKNOWN ·Phase: PHASE1

A Study of DB-1202 Monotherapy in Advanced Solid Tumors

NCT05785728 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies

NCT03317496 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors

NCT07166601 ·Status: RECRUITING ·Phase: PHASE1